Dr. Dowdy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1000 E Eager St
Baltimore, MD 21202Phone+1 410-502-8495Fax+1 410-522-5136
Education & Training
- University of California (San Francisco)Residency, Internal Medicine, 2008 - 2011
- Johns Hopkins University School of MedicineClass of 2008
Certifications & Licensure
- CA State Medical License 2009 - Present
- MD State Medical License 2011 - 2026
- American Board of Internal Medicine Internal Medicine
Clinical Trials
- Options for Delivering Isoniazid-Rifapentine (3HP) for TB Prevention (3HP Options Implementation Trial) Start of enrollment: 2020 Jul 13
- Clinic-based Versus Hotspot-focused Active TB Case Finding Start of enrollment: 2022 Jun 01
Roles: Contact
- Comparative Effectiveness/Implementation of TB Case Finding in Rural South Africa Start of enrollment: 2016 Jul 18
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Preferences of people living with HIV for features of tuberculosis preventive treatment regimens in Uganda: a discrete choice experiment.Hélène E Aschmann, Allan Musinguzi, Jillian L Kadota, Catherine Namale, Juliet Kakeeto
Journal of the International AIDS Society. 2024-12-01 - Impact of a multicomponent strategy including decentralized molecular testing for tuberculosis on mortality: planned analysis of a cluster-randomized trial in Uganda.Achilles Katamba, Tessa Mochizuki, Talemwa Nalugwa, Mariam Nantale, Denis Oyuku
Eclinicalmedicine. 2024-12-01 - Adverse Events Reported During Weekly Isoniazid-Rifapentine (3HP) Tuberculosis Preventive Treatment Among People With Human Immunodeficiency Virus in Uganda.Jillian L Kadota, Allan Musinguzi, Hélène E Aschmann, Lydia Akello, Fred Welishe
Open Forum Infectious Diseases. 2024-11-01
Journal Articles
- Maternal Motivation to Take Preventive Therapy in Antepartum and Postpartum Among HIV-Positive Pregnant Women in South Africa: A Choice ExperimentDavid W Dowdy, Jonathan Golub, AIDS and Behavior
- The Importance of Heterogeneity to the Epidemiology of TuberculosisDavid Dowdy, MD, Clinical Infectious Diseases
- Screening for Tuberculosis with Xpert MTB/RIF Versus Fluorescent Microscopy Among Adults Newly Diagnosed with HIV in Rural Malawi: A Cluster Randomized Trial (CHEPETSA)Richard E Chaisson, David W Dowdy, Clinical Infectious Diseases
Press Mentions
- Jury in Baltimore Opioid Trial to Begin Deliberating ‘Biggest and Most Important Case in the City’s History’November 7th, 2024
- Wildfires May Threaten Inpatient Health Care Facilities in Many California Counties, Study SaysMay 2nd, 2023
- Why COVID-19 Cases May Continue to Decline in the United StatesApril 7th, 2022
- Join now to see all
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/david-dowdy
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: